US Patent Issued to VIRBAC on Nov. 25 for "Use of glucocorticoids for the treatment of epithelial microbial infections of a fluid containing organ with a natural exterior orifice in mammals" (French, British Inventors)

ALEXANDRIA, Va., Nov. 25 -- United States Patent no. 12,478,629, issued on Nov. 25, was assigned to VIRBAC (Caarros, France).

"Use of glucocorticoids for the treatment of epithelial microbial infections of a fluid containing organ with a natural exterior orifice in mammals" was invented by Bertrand Havrileck (Nice, France), Pierre Jasmin (Saint-Jeannet, France) and David Mcgahie (Ballymena, Great Britain).

According to the abstract* released by the U.S. Patent & Trademark Office: "The disclosure is directed to glucocorticoids for the treatment of epithelial microbial infections in fluid-containing organ having a natural exterior orifice in mammals; this new therapeutic use finds particular interest in the treatment of epithelial microbial...